{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:11:12Z","timestamp":1787314272683,"version":"build-2736575974"},"reference-count":194,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["EMDR\/SG\/15\/2023-5901"],"award-info":[{"award-number":["EMDR\/SG\/15\/2023-5901"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.humimm.2025.111301","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:51:25Z","timestamp":1742932285000},"page":"111301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The evolving role of B cells in malignancies"],"prefix":"10.1016","volume":"86","author":[{"given":"Soham","family":"Bindu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshni","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-6688","authenticated-orcid":false,"given":"Koustav","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6695","key":"10.1016\/j.humimm.2025.111301_b0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.trre.2010.01.004","article-title":"The yin and yang of B cells in graft rejection and tolerance","volume":"24","author":"Zarkhin","year":"2010","journal-title":"Transplant. Rev. (Orlando)"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0015","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41467-021-22300-2","article-title":"Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling","volume":"12","author":"Hu","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.autrev.2016.03.006","article-title":"Therapeutic strategies targeting B-cells in multiple sclerosis","volume":"15","author":"Milo","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0025","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.autrev.2014.08.020","article-title":"The efficacy of novel B cell biologics as the future of SLE treatment: a review","volume":"13","author":"Kamal","year":"2014","journal-title":"Autoimmunity Rev."},{"issue":"10086","key":"10.1016\/j.humimm.2025.111301_b0030","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"24","key":"10.1016\/j.humimm.2025.111301_b0035","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic Significance of Tumor-Infiltrating B Cells and Plasma Cells in Human Cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clinical Cancer Res."},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0040","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/intimm\/dxw007","article-title":"Mammary-tumor-educated B cells acquire LAP\/TGF-\u03b2 and PD-L1 expression and suppress anti-tumor immune responses","volume":"28","author":"Zhang","year":"2016","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0055","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/2326-6066.CIR-17-0710","article-title":"IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer","volume":"6","author":"Mirlekar","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41423-018-0027-x","article-title":"Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0065","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0070","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2025.111301_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"Onitilo","year":"2009","journal-title":"Clin. Med. Res."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1200\/JCO.18.01010","article-title":"Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers","volume":"37","author":"Loi","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/lgbt.2021.0146","article-title":"Relationship between sexual orientation and human papillomavirus-related oral cancer knowledge and awareness","volume":"10","author":"Dougherty","year":"2023","journal-title":"LGBT Health"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0090","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3748\/wjg.v28.i11.1088","article-title":"B cells in pancreatic cancer stroma","volume":"28","author":"Delvecchio","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.humimm.2025.111301_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1152551","article-title":"Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies","volume":"14","author":"Senturk","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13058-020-01283-w","article-title":"Association of TILs with clinical parameters, Recurrence Score\u00ae results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial","volume":"22","author":"Kolberg-Liedtke","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"12","key":"10.1016\/j.humimm.2025.111301_b0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12967-016-0990-x","article-title":"Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients","volume":"14","author":"Seremet","year":"2016","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0115","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/cancers15051517","article-title":"B Cells in Breast Cancer Pathology","volume":"15","author":"Li","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0120","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12885-020-07654-y","article-title":"Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis","volume":"20","author":"Gao","year":"2020","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.humimm.2025.111301_b0125","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2025.111301_b0135","article-title":"B-cell editing: an emerging alternative of precision oncotherapy","author":"Choudhury","year":"2024","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12865-024-00620-4","article-title":"Atypical memory B cells increase in the peripheral blood of patients with breast cancer regardless of lymph node involvement","volume":"25","author":"Azizi","year":"2024","journal-title":"BMC Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0145","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ccell.2024.09.011","article-title":"A pan-cancer single-cell RNA-seq atlas of intratumoral B cells","volume":"42","author":"Fitzsimons","year":"2024","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.humimm.2025.111301_b0150","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1016\/j.cell.2024.06.038","article-title":"Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"issue":"221","key":"10.1016\/j.humimm.2025.111301_b0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007323","article-title":"Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions","volume":"6","author":"Maldonado","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.humimm.2025.111301_b0160","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1073\/pnas.1133324100","article-title":"Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses","volume":"100","author":"Gnjatic","year":"2003","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0165","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.4049\/jimmunol.1001323","article-title":"CD20+ B cells: the other tumor-infiltrating lymphocytes","volume":"185","author":"Nelson","year":"2010","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2025.111301_b0170","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0175","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","article-title":"The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma","volume":"12","author":"Hao","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0180","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2025.111301_b0185","article-title":"Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma","volume":"14","author":"Bao","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.07.019","article-title":"Interleukin 35 Regulatory B Cells","volume":"433","author":"Choi","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0195","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cytogfr.2015.07.013","article-title":"Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases","volume":"26","author":"Egwuagu","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tips.2012.04.003","article-title":"Crosstalk between TGF-\u03b2 signaling and the microRNA machinery","volume":"33","author":"Butz","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrc.2016.7","article-title":"Pancreatic cancer: Spotlight on B cells","volume":"16","author":"Seton-Rogers","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"19","key":"10.1016\/j.humimm.2025.111301_b0210","doi-asserted-by":"crossref","first-page":"14803","DOI":"10.18632\/oncotarget.22976","article-title":"Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1\/PD-L1 pathway","volume":"9","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0215","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.annonc.2021.02.009","article-title":"Targeting B cells in pancreatic adenocarcinoma: does RESOLVE resolve the question?","volume":"32","author":"Philip","year":"2021","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0220","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI80007","article-title":"Immunity, inflammation, and cancer: an eternal fight between good and evil","volume":"125","author":"Shalapour","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2025.111301_b0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-12-30","article-title":"Tumor infiltrating B-cells are increased in prostate cancer tissue","volume":"12","author":"Woo","year":"2014","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0230","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/s41467-021-21245-w","article-title":"Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes","volume":"12","author":"Weiner","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0235","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/cancers15030920","article-title":"Immune-Activated B Cells Are Dominant in Prostate Cancer","volume":"15","author":"Saudi","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjh.17879","article-title":"B-cell acute lymphoblastic leukaemia: recent discoveries in molecular pathology, their prognostic significance, and a review of the current classification","volume":"197","author":"Yeung","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cas.15583","article-title":"Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia","volume":"114","author":"Yasuda","year":"2023","journal-title":"Cancer Sci."},{"issue":"10230","key":"10.1016\/j.humimm.2025.111301_b0250","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"23","key":"10.1016\/j.humimm.2025.111301_b0255","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.4161\/cc.8.23.10035","article-title":"Pre-B cell receptor signaling in acute lymphoblastic leukemia","volume":"8","author":"Nahar","year":"2009","journal-title":"Cell Cycle (Georgetown, Tex.),"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0260","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1038\/s41598-022-16152-z","article-title":"B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12","volume":"12","author":"Hunter","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0265","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with b-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.humimm.2025.111301_b0270","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJM197804202981603","article-title":"Pre-b-cell leukemia","volume":"298","author":"Vogler","year":"1978","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12967-017-1252-2","article-title":"Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy","volume":"15","author":"Goswami","year":"2017","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0280","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7136","key":"10.1016\/j.humimm.2025.111301_b0285","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nature05656","article-title":"Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin","volume":"446","author":"Luo","year":"2007","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0290","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.3390\/ijms24108764","article-title":"Overview on Aneuploidy in Childhood B-Cell Acute Lymphoblastic Leukemia","volume":"24","author":"Panuciak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0295","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0300","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02783-22","article-title":"Impaired humoral immunity identified in inactivated SARS-CoV-2 vaccine recipients without anti-spike RBD antibodies","volume":"11","author":"Sun","year":"2023","journal-title":"Microbiol Spectr."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0305","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/vaccines11071196","article-title":"Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization","volume":"11","author":"Verheul","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.humimm.2025.111301_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117436","article-title":"Tumor-infiltrating b cells: their dual mechanistic roles in the tumor microenvironment","volume":"179","author":"Xue","year":"2024","journal-title":"Biomed. & Pharmacother."},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0315","first-page":"242","article-title":"Recurrence after surgery in patients with NSCLC","volume":"3","author":"Uramoto","year":"2014","journal-title":"Transl. Lung Cancer Res."},{"issue":"7791","key":"10.1016\/j.humimm.2025.111301_b0320","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"7791","key":"10.1016\/j.humimm.2025.111301_b0325","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2025.111301_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1169084","article-title":"Telitacicept for autoimmune nephropathy","volume":"14","author":"Cai","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0335","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000499931","article-title":"St. Gallen\/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment","volume":"14","author":"Balic","year":"2019","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1258\/0022215001903870","article-title":"Identification and typing of human papillomavirus (HPV) in squamous cell carcinoma of the oral cavity and oropharynx","volume":"114","author":"Niv","year":"2000","journal-title":"J. Laryngol. Otol."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0345","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0350","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","article-title":"BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis","volume":"12","author":"Luther","year":"2000","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0355","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","article-title":"Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing","volume":"14","author":"Sfanos","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2025.111301_b0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","article-title":"Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.humimm.2025.111301_b0365","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/1759-7714.14873","article-title":"COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy","volume":"14","author":"Liu","year":"2023","journal-title":"Thoracic Cancer"},{"issue":"02","key":"10.1016\/j.humimm.2025.111301_b0370","first-page":"106","article-title":"\u201ca.b.c.\u201d of immunotherapy in hematological malignancies\u2026promise and perils. Indian Journal of Medical and Paediatric","volume":"45","author":"Bajpai","year":"2022","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0375","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/rheumatology\/key394","article-title":"Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases","volume":"58","author":"Wijetilleka","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.humimm.2025.111301_b0380","doi-asserted-by":"crossref","unstructured":"Suparak, S., Bumroongthai, K., Jantapalaboon, D., Pairoung, P., Wongkidakarn, S., Yodtub, C., \u2026 & Mahasirimongkol, S. (2022). The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine after a single or 2 shots of inactivated covid-19 vaccine in healthy adults.. Doi: 10.1101\/2022.10.18.512323","DOI":"10.1101\/2022.10.18.512323"},{"key":"10.1016\/j.humimm.2025.111301_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1021396","article-title":"Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study","volume":"13","author":"Fedele","year":"2022","journal-title":"Front. Immunol."},{"issue":"94","key":"10.1016\/j.humimm.2025.111301_b0390","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi8039","article-title":"AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans","volume":"9","author":"Grigoryan","year":"2024","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0395","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0400","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.humimm.2025.111301_b0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: Global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0415","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0420","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10555-021-09968-0","article-title":"Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer","volume":"40","author":"Nelson","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.humimm.2025.111301_b0425","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.21037\/tlcr-20-788","article-title":"B cells in lung cancer-not just a bystander cell: a literature review","volume":"10","author":"Leong","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0430","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/cells8050449","article-title":"The B-side of Cancer Immunity: The Underrated Tune","volume":"8","author":"Largeot","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.humimm.2025.111301_b0435","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40425-016-0145-x","article-title":"B cell regulation of the anti-tumor response and role in carcinogenesis","volume":"4","author":"Schwartz","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"6920","key":"10.1016\/j.humimm.2025.111301_b0440","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature01318","article-title":"SAP is required for generating long-term humoral immunity","volume":"421","author":"Crotty","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0445","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0952-7915(99)80029-6","article-title":"B cell memory and the long-lived plasma cell","volume":"11","author":"McHeyzer-Williams","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.humimm.2025.111301_b0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1198665","article-title":"Deep immune B and plasma cell repertoire in non-small cell lung cancer","volume":"14","author":"Patel","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0455","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00262-019-02461-2","article-title":"The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer","volume":"69","author":"Patel","year":"2020","journal-title":"Cancer Immunology, Immunotherapy: CII"},{"issue":"12","key":"10.1016\/j.humimm.2025.111301_b0460","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","article-title":"CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer","volume":"18","author":"Nielsen","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.humimm.2025.111301_b0465","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","article-title":"Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer","volume":"14","author":"Al-Shibli","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0470","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2007.08.089","article-title":"A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years","volume":"108","author":"Nedergaard","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"7791","key":"10.1016\/j.humimm.2025.111301_b0475","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0480","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","article-title":"Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer","volume":"40","author":"Patil","year":"2022","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0485","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2022.02.008","article-title":"Intratumoral plasma cells: More than a predictive marker of response to anti-PD-L1 treatment in lung cancer?","volume":"40","author":"Teillaud","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41392-022-01297-0","article-title":"Targeted therapy for head and neck cancer: signaling pathways and clinical studies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0495","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/cells10020389","article-title":"Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression","volume":"10","author":"Miranda-Galvis","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.humimm.2025.111301_b0500","doi-asserted-by":"crossref","unstructured":"Olkhanud, P. B., Damdinsuren, B., Bodogai, M., Gress, R. E., Sen, R., Wejksza, K., Malchinkhuu, E., Wersto, R. P., & Biragyn, A. (2011). Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. Cancer research, 71(10), 3505\u20133515. Doi: 10.1158\/0008-5472.CAN-10-4316Kessel, A., Haj, T., Peri, R., Snir, A., Melamed, D., Sabo, E., & Toubi, E. (2012). Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmunity reviews, 11(9), 670\u2013677. Doi: 10.1016\/j.autrev.2011.11.018.","DOI":"10.1158\/0008-5472.CAN-10-4316"},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0505","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2025.111301_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.678127","article-title":"B cell orchestration of anti-tumor immune responses: a matter of cell localization and communication","volume":"9","author":"Kinker","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"21","key":"10.1016\/j.humimm.2025.111301_b0515","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.3390\/cancers13215383","article-title":"The Role of B Cells in Head and Neck Cancer","volume":"13","author":"Gavrielatou","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0520","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.annonc.2023.12.011","article-title":"B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma","volume":"35","author":"Gavrielatou","year":"2024","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0525","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/cancers14020294","article-title":"Potential Role of CXCL13\/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer","volume":"14","author":"Hsieh","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31061","article-title":"Oral and periodontal manifestation related during human papilloma virus infections: Update on early prognostic factors","volume":"10","author":"Amato","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0535","article-title":"A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer","volume":"14","author":"Pathak","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0540","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.humimm.2025.111301_b0545","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-19-3211","article-title":"B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade","volume":"26","author":"Kim","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"422","key":"10.1016\/j.humimm.2025.111301_b0550","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaf8036","article-title":"B cells fuel pancreatic cancer","volume":"9","author":"Ferrarelli","year":"2016","journal-title":"Sci. Signal."},{"issue":"8","key":"10.1016\/j.humimm.2025.111301_b0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071367","article-title":"Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer","volume":"8","author":"Koizumi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0560","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12884-019-2324-5","article-title":"B cell activation factor (BAFF) induces inflammation in the human fallopian tube leading to tubal pregnancy","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"10.1016\/j.humimm.2025.111301_b0565","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/cancers15061791","article-title":"The BAFF-APRIL System in Cancer","volume":"15","author":"Ullah","year":"2023","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0570","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pan.2024.01.005","article-title":"Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer","volume":"24","author":"Agnihotri","year":"2024","journal-title":"Pancreatology"},{"key":"10.1016\/j.humimm.2025.111301_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1230306","article-title":"B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients","volume":"14","author":"Vietsch","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0580","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of Prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World Journal of Oncology"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0585","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.humimm.2025.111301_b0590","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/CMAR.S32839","article-title":"The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development","volume":"4","author":"Corn","year":"2012","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.humimm.2025.111301_b0595","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-015-0098-5","article-title":"Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment","volume":"3","author":"Olsson","year":"2015","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0600","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.yexcr.2013.03.005","article-title":"B cells and their mediators as targets for therapy in solid tumors","volume":"319","author":"Gunderson","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.humimm.2025.111301_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.958756","article-title":"The role of B cells in cancer development","volume":"12","author":"Tan","year":"2022","journal-title":"Front. Oncol."},{"issue":"7885","key":"10.1016\/j.humimm.2025.111301_b0610","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","article-title":"B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity","volume":"599","author":"Zhang","year":"2021","journal-title":"Nature"},{"issue":"1\u20133","key":"10.1016\/j.humimm.2025.111301_b0615","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12026-013-8472-1","article-title":"B cell regulation of anti-tumor immune response","volume":"57","author":"Zhang","year":"2013","journal-title":"Immunol. Res."},{"issue":"38","key":"10.1016\/j.humimm.2025.111301_b0620","doi-asserted-by":"crossref","first-page":"23674","DOI":"10.1073\/pnas.2010981117","article-title":"Circulation of gut-preactivated na\u00efve CD8+ T cells enhances antitumor immunity in B cell-defective mice","volume":"117","author":"Akrami","year":"2020","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0625","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-7613(01)00094-2","article-title":"Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue","volume":"14","author":"Schrama","year":"2001","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0630","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7286","key":"10.1016\/j.humimm.2025.111301_b0635","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature08782","article-title":"B-cell-derived lymphotoxin promotes castration-resistant prostate cancer","volume":"464","author":"Ammirante","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.humimm.2025.111301_b0640","article-title":"A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade","volume":"15","author":"Ekpa","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0645","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3801","article-title":"The early history of B cells","volume":"15","author":"Cooper","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0650","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0655","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0660","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1038\/s41467-019-13069-6","article-title":"Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk","volume":"10","author":"Vijayakrishnan","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.humimm.2025.111301_b0665","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.humimm.2025.111301_b0670","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.12659\/MSM.915556","article-title":"The Role of Regulatory B Cells in Patients with Acute Myeloid Leukemia","volume":"25","author":"Lv","year":"2019","journal-title":"Med. Sci. Monitor"},{"issue":"6","key":"10.1016\/j.humimm.2025.111301_b0675","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1097\/HS9.0000000000000914","article-title":"An Overview of Targeted Therapies in Acute Myeloid Leukemia","volume":"7","author":"Turkalj","year":"2023","journal-title":"HemaSphere"},{"issue":"21","key":"10.1016\/j.humimm.2025.111301_b0680","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/1078-0432.CCR-12-3497","article-title":"Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma","volume":"19","author":"Shi","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0685","first-page":"27","article-title":"An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia","volume":"4","author":"Lasry","year":"2023","journal-title":"Nature Cancer"},{"issue":"30","key":"10.1016\/j.humimm.2025.111301_b0690","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba6493","article-title":"Expression of inhibitory receptors by B cells in chronic human infectious diseases restricts responses to membrane-associated antigens","volume":"6","author":"Ambegaonkar","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0695","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.21873\/anticanres.11107","article-title":"High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction","volume":"36","author":"Knief","year":"2016","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0700","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2013.01.036","article-title":"The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer","volume":"333","author":"Lohr","year":"2013","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0705","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","article-title":"FcRgamma activation regulates inflammation-associated squamous carcinogenesis","volume":"17","author":"Andreu","year":"2010","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0710","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1586\/eci.10.9","article-title":"Mechanisms of action of intravenous immunoglobulins","volume":"6","author":"Baerenwaldt","year":"2010","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0715","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0720","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0725","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s00262-021-02914-7","article-title":"Activated B lymphocytes and tumor cell lysate as an effective cellular cancer vaccine","volume":"70","author":"Oxley","year":"2021","journal-title":"Cancer Immunol., Immunotherapy: CII"},{"issue":"6","key":"10.1016\/j.humimm.2025.111301_b0730","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/vaccines10060879","article-title":"B-Cell-Based Immunotherapy: A Promising New Alternative","volume":"10","author":"Gupta","year":"2022","journal-title":"Vaccines"},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0735","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.4049\/jimmunol.1701351","article-title":"A novel platform for cancer vaccines: antigen-selective delivery to splenic marginal zone B cells via repeated injections of PEGylated liposomes","volume":"201","author":"Shimizu","year":"2018","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.humimm.2025.111301_b0740","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2217\/fon-2020-0224","article-title":"B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine","volume":"16","author":"Kaumaya","year":"2020","journal-title":"Future Oncol. (London, England)"},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0745","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"issue":"17","key":"10.1016\/j.humimm.2025.111301_b0750","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1158\/1078-0432.CCR-20-0305","article-title":"The Role of Antigen Spreading in the Efficacy of Immunotherapies","volume":"26","author":"Brossart","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0755","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-5699(93)90274-O","article-title":"Do B cells drive the diversification of immune responses?","volume":"14","author":"Mamula","year":"1993","journal-title":"Immunol. Today"},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077346","article-title":"Antigen presenting B cells facilitate CD4 T cell cooperation resulting in enhanced generation of effector and memory CD4 T cells","volume":"8","author":"Kroeger","year":"2013","journal-title":"PLoS One"},{"issue":"482","key":"10.1016\/j.humimm.2025.111301_b0765","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav1648","article-title":"Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus","volume":"11","author":"Kansal","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0770","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0775","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2337\/db12-0006","article-title":"B-cell cross-presentation of autologous antigen precipitates diabetes","volume":"61","author":"Mari\u00f1o","year":"2012","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0780","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.236711","article-title":"TLR7 trafficking and signaling in B cells is regulated by the MHCII-associated invariant chain","volume":"133","author":"Tohme","year":"2020","journal-title":"J. Cell Sci."},{"issue":"8","key":"10.1016\/j.humimm.2025.111301_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109591","article-title":"B cells promote CD8 T cell primary and memory responses to subunit vaccines","volume":"36","author":"Klarquist","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.humimm.2025.111301_b0790","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"Oncoimmunology"},{"issue":"8","key":"10.1016\/j.humimm.2025.111301_b0795","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00262-016-1848-z","article-title":"Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models","volume":"65","author":"Guy","year":"2016","journal-title":"Cancer Immunol., Immunother.: CII"},{"issue":"7","key":"10.1016\/j.humimm.2025.111301_b0800","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.humimm.2025.111301_b0805","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157665","article-title":"B cell receptor signaling strength modulates cancer immunity","volume":"132","author":"Ye","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.humimm.2025.111301_b0810","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nature Cancer"},{"issue":"25","key":"10.1016\/j.humimm.2025.111301_b0815","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0820","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/2326-6066.CIR-20-0949","article-title":"CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses","volume":"9","author":"Wennhold","year":"2021","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"10.1016\/j.humimm.2025.111301_b0825","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41571-021-00508-x","article-title":"Beneficial autoimmunity improves cancer prognosis","volume":"18","author":"Zitvogel","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.humimm.2025.111301_b0830","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1122977","article-title":"First in man study: Bcl-Xl_42-CAF\u00ae09b vaccines in patients with locally advanced prostate cancer","volume":"14","author":"M\u00f8rk","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0835","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5483\/BMBRep.2022.55.1.133","article-title":"Immune cell-derived small extracellular vesicles in cancer treatment","volume":"55","author":"Choi","year":"2022","journal-title":"BMB Rep."},{"key":"10.1016\/j.humimm.2025.111301_b0840","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.939356","article-title":"Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers","volume":"12","author":"Ede","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100361","article-title":"Vaccination against Her-2\/neu, with focus on peptide-based vaccines","volume":"7","author":"Tobias","year":"2022","journal-title":"ESMO Open"},{"issue":"12","key":"10.1016\/j.humimm.2025.111301_b0850","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.30408","article-title":"HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research","volume":"139","author":"Pietrantonio","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.humimm.2025.111301_b0855","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-18-3997","article-title":"Phase I Immunotherapy Trial with Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Patients with Advanced Solid Tumors","volume":"25","author":"Bekaii-Saab","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0860","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12885-017-3098-7","article-title":"Enhanced and long term immunogenicity of a Her-2\/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide","volume":"17","author":"Tobias","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humimm.2025.111301_b0865","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40364-023-00460-1","article-title":"Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomark Res."},{"issue":"23","key":"10.1016\/j.humimm.2025.111301_b0870","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-23-0620","article-title":"The Evolving Landscape of B Cells in Cancer Metastasis","volume":"83","author":"Ramos","year":"2023","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.humimm.2025.111301_b0875","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41590-024-01821-0","article-title":"Predictability of B cell clonal persistence and immunosurveillance in breast cancer","volume":"25","author":"Sammut","year":"2024","journal-title":"Nat. Immunol."},{"issue":"7957","key":"10.1016\/j.humimm.2025.111301_b0880","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","article-title":"Antibodies against endogenous retroviruses promote lung cancer immunotherapy","volume":"616","author":"Ng","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2025.111301_b0885","article-title":"B cell deficiency promotes the initiation and progression of lung cancer","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Oncol."},{"issue":"17","key":"10.1016\/j.humimm.2025.111301_b0890","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.3390\/cancers14174298","article-title":"Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients","volume":"14","author":"Phanthunane","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.humimm.2025.111301_b0895","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.34555","article-title":"Regulatory B cells producing IL-10 are increased in human tumor draining lymph nodes","volume":"153","author":"Piersiala","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.humimm.2025.111301_b0900","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867902","article-title":"B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma","volume":"13","author":"Minici","year":"2022","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.humimm.2025.111301_b0905","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172449","article-title":"Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens","volume":"8","author":"Yao","year":"2023","journal-title":"JCI Insight"},{"issue":"17","key":"10.1016\/j.humimm.2025.111301_b0910","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.humimm.2025.111301_b0915","doi-asserted-by":"crossref","unstructured":"Halabi, S., Roy, A., Rydzewska, L., Guo, S., Godolphin, P., Hussain, M., Tangen, C., Thompson, I., Xie, W., Carducci, M. A., Smith, M. R., Morris, M. J., Gravis, G., Dearnaley, D. P., Verhagen, P., Goto, T., James, N., Buyse, M. E., Tierney, J. F., Sweeney, C., \u2026 STOPCAP\/ICECaP Collaboration (2024). Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 42(9), 1044\u20131054. Doi: 10.1200\/JCO.23.01535","DOI":"10.1200\/JCO.23.01535"},{"issue":"10","key":"10.1016\/j.humimm.2025.111301_b0920","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.trecan.2023.06.009","article-title":"Advances in the treatment of metastatic prostate cancer","volume":"9","author":"Gebrael","year":"2023","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0925","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.JAA.0000995680.52352.b5","article-title":"Acute myeloid leukemia","volume":"37","author":"Becker","year":"2024","journal-title":"JAAPA"},{"issue":"2","key":"10.1016\/j.humimm.2025.111301_b0930","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.humimm.2025.111301_b0935","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241263489","article-title":"Recent advances in CAR-T therapy for the treatment of acute myeloid leukemia","volume":"15","author":"Zha","year":"2024","journal-title":"Ther. Adv. Hematol."},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0940","article-title":"Acute lymphoblastic leukemia experience: epidemiology and outcome of two different regimens","volume":"5","author":"Abbasi","year":"2013","journal-title":"Mediterranean J. Hematol. Infectious Diseases"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0945","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","article-title":"Acute lymphoblastic leukaemia","volume":"10","author":"Pagliaro","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"17","key":"10.1016\/j.humimm.2025.111301_b0950","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.3390\/cancers14174318","article-title":"Current Progress of CAR-NK Therapy in Cancer Treatment","volume":"14","author":"Pang","year":"2022","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.humimm.2025.111301_b0955","article-title":"CAR-T cell therapy for hematological malignancies: History, status and promise","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.humimm.2025.111301_b0960","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s40164-024-00570-y","article-title":"Crispr\/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications","volume":"13","author":"Eng","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"7978","key":"10.1016\/j.humimm.2025.111301_b0965","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-023-06496-5","article-title":"Epitope editing enables targeted immunotherapy of acute myeloid leukaemia","volume":"621","author":"Casirati","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2025.111301_b0970","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1354825","article-title":"Revolutionizing cancer treatment: enhancing CAR-T cell therapy with CRISPR\/Cas9 gene editing technology","volume":"15","author":"Tao","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885925000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:28:26Z","timestamp":1777696106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885925000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":194,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0198885925000722"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111301","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving role of B cells in malignancies","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2025.111301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111301"}}